Tricares

Developer of a minimally invasive tricuspid valve replacement system. This system is designed to treat tricuspid regurgitation, a serious heart condition, without the need for open-heart surgery. The company focuses on d

placeAschheim, Bavaria, Germany calendar_todayFounded 2013 groups12 employees language tricares.com

Registered entities

Innovation

15 patent families (10 granted) — focus: Human necessities; filing pace steady. Cited 720 times.

YearFilings
20151
20161
20172
20183
20195
202010
20219
20228
20235
20248
20257
20264

Investor mix

12 investors on record; lead investors include 415 CAPITAL.

Investor typeCountShare
Venture capital542%
Private equity433%
Accelerator & incubator18%
Other / undisclosed217%
Coming soon